Clinical Trial Update: DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update for DC1 therapy (DecipHER) in early-stage triple-negative breast cancer and ER-low positive breast cancer. The study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• DC1 (DC1)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Triple Negative Breast Cancer, HER2-negative Breast Cancer | Phase 1 | Status: RECRUITING